Integer Holdings Co. (ITGR) Trading Down 3.9%
Integer Holdings Co. (NASDAQ:ITGR) was down 3.9% on Monday . The stock traded as low as $23.07 and last traded at $23.50, with a volume of 122,978 shares trading hands. The stock had previously closed at $24.45.
Several equities research analysts have recently weighed in on ITGR shares. TheStreet cut Integer Holdings from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Zacks Investment Research raised Integer Holdings from a “sell” rating to a “hold” rating in a research report on Thursday, May 19th. Finally, Sterne Agee CRT reissued a “buy” rating on shares of Integer Holdings in a research report on Monday, May 16th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $57.00.
The company has a 50-day moving average of $0.00 and a 200 day moving average of $0.00. The stock’s market capitalization is $734.41 million.
Integer Holdings (NASDAQ:ITGR) last released its earnings results on Thursday, July 28th. The company reported $0.56 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.70 by $0.14. The business earned $348.38 million during the quarter, compared to analysts’ expectations of $356.72 million. The business’s quarterly revenue was up 99.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.73 EPS. Equities analysts predict that Integer Holdings Co. will post $2.64 EPS for the current year.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.